AG真人官方

Aehr Test Systems (ticker AEHR) has filed a Form 144 indicating a planned sale of 3,000 common shares through Fidelity Brokerage Services on 15 July 2025. The proposed sale represents approximately 0.01 % of the company鈥檚 29,771,410 shares outstanding and carries an aggregate market value of $42,390.

The shares to be sold were acquired via seven separate restricted-stock vesting events between 18 January 2024 and 11 January 2025, totaling exactly the 3,000 shares being registered. The filer reports no other sales in the past three months and affirms awareness of no undisclosed material adverse information about the company, in line with Rule 144 requirements.

Given the small size of the transaction relative to float and its origin from routine equity compensation, the filing is unlikely to be financially material for most investors, but it does add a data point to insider-trading dashboards.

Aehr Test Systems (AEHR) filed a Form 4 disclosing an insider equity transaction by President & CEO Gayn Erickson on 14 July 2025. The filing reports a Code F disposition of 4,518 common shares at an accounting price of $13.86 per share. Code F indicates the shares were withheld by the company to satisfy tax obligations triggered by the vesting of restricted stock units (RSUs) and restricted shares; it is not an open-market sale.

Following the withholding, Erickson鈥檚 direct ownership stands at 272,511 shares, while an additional 291,088 shares are held indirectly through a trust, for an aggregate insider position of roughly 563,599 shares. No derivative securities were acquired or disposed of, and no 10b5-1 trading plan was indicated.

The transaction represents a minor 0.8% reduction of Erickson鈥檚 total reported holdings and is routine for RSU vesting events. Investors typically view Code F tax-withholding transactions as neutral because they do not reflect an active decision to sell in the open market.

Aehr Test Systems (AEHR) filed a Form 4 showing an insider administrative share transaction. Executive VP of Sales & Marketing Vernon Rogers had 1,058 common shares withheld on 14-Jul-2025 to cover payroll taxes triggered by the vesting of restricted stock units (Transaction Code F). The shares were valued at $13.86 each, implying a tax-settlement value of roughly $14,665. This was not an open-market sale; it simply reduced the executive鈥檚 stake used for tax remittance. Following the withholding, Rogers continues to hold 68,578 AEHR shares, which still includes unvested RSUs. No derivative securities were reported. The filing does not indicate any change in strategic outlook or corporate fundamentals; it is a routine compliance event that should have minimal market impact.

Aehr Test Systems (AEHR) 鈥� Form 4 insider filing: Chief Technology Officer Donald P. Richmond II had 811 common shares withheld on 14 Jul 2025 (Transaction Code F) to cover tax obligations triggered by the vesting of restricted stock units (RSUs) at an indicated price of $13.86 per share. The filing explicitly notes that this is not an open-market sale; the shares were surrendered back to the issuer. After the withholding, Richmond still beneficially owns 214,694 shares, a figure that includes unvested RSUs. No derivative securities were reported, and there were no purchases or discretionary sales. Given the small number of shares involved (鈮�0.4 % of the insider鈥檚 holdings) and the routine nature of tax-related withholding, the transaction is viewed as administrative and immaterial to the company鈥檚 investment thesis.

The Form 4 filing discloses a routine equity withholding transaction by Vernon Rogers, Executive Vice President of Sales & Marketing at Aehr Test Systems (AEHR).

• Transaction date: 07/11/2025
• Security: Common stock
• Transaction code: F 鈥� shares withheld solely to satisfy tax-withholding obligations upon the vesting of restricted stock units (RSUs)
• Shares affected: 304 shares at an indicated price of $14.11
• Proceeds to insider: None 鈥� the transaction is not a sale for the insider鈥檚 benefit
• Post-transaction holdings: 69,636 shares, which include unvested RSUs

The reporting person remains a corporate officer and continues to hold a sizeable equity position. As the event involves a small number of shares relative to overall ownership and stems from tax obligations rather than discretionary trading, the filing is generally viewed as administrative and non-material for investors.

Form 4 filing overview

On 07/11/2025, Aehr Test Systems (AEHR) Chief Technology Officer Donald P. Richmond II reported a tax-related share withholding. The company retained 225 shares of common stock at $14.11 each to satisfy withholding obligations triggered by the vesting of restricted stock units. This administrative entry is coded 鈥淔,鈥� indicating no open-market sale or purchase. After the transaction, Richmond鈥檚 direct ownership totals 215,505 shares, a figure that still includes unvested RSUs. No derivative security movements were disclosed.

The 225-share amount represents far less than 1 % of the insider鈥檚 holdings and does not alter the company鈥檚 share count or insider ownership structure in any material way, suggesting a neutral impact for investors.

Aehr Test Systems (AEHR) 鈥� Form 4 insider filing

On 07/11/2025, President & CEO Gayn Erickson reported an automatic share withholding related to the vesting of restricted stock units (Transaction Code F). A total of 1,052 common shares were surrendered at $14.11 solely to cover tax-withholding obligations; no open-market sale occurred.

Following the transaction, Erickson鈥檚 ownership stands at 277,029 shares held directly and 291,088 shares held indirectly through a trust. The filing reiterates that the reported figure includes unvested RSUs and restricted shares.

Because the event is tax-related and involves a small fraction of the executive鈥檚 total holdings, it is viewed as neutral from a market-impact perspective.

On 07/11/2025, Aehr Test Systems (AEHR) filed a Form 4 detailing a routine Code F transaction by Vice President Alistair N. Sporck. The company withheld 312 common shares at an implied price of $14.11 to satisfy tax obligations triggered by the vesting of restricted stock units (RSUs); no open-market sale occurred. After the withholding, Sporck鈥檚 direct ownership totals 33,808 shares, with an additional 3,993 shares held indirectly through a trust. The total includes unvested RSUs, and no derivative securities were involved. Because the activity is purely administrative and does not alter the insider鈥檚 investment exposure, the filing is viewed as neutral for investors.

Form 4 snapshot: On 07/10/2025, Grove Collaborative Holdings, Inc. (ticker: GROV) filed a Form 4 disclosing that director David A. Glazer was granted 59,200 Restricted Stock Units (RSUs). Each RSU represents one share of Class A common stock.

Key details of the award

• Transaction code: A (award/grant)
• Exercise price: $0 (no cash outlay required)
• Vesting: RSUs fully vest on the earlier of May 15 2026 or the company鈥檚 2026 Annual Meeting of Stockholders.
• Expiration: None鈥擱SUs convert directly into shares once vested.
• Ownership after grant: 59,200 shares held directly by the reporting person.

No shares were sold or disposed of; the filing only records an equity-based compensation grant. The transaction increases the director鈥檚 alignment with shareholders, but does not involve open-market purchasing, cash inflow, or changes to the overall share count. The Form 4 was signed on 07/11/2025 by an attorney-in-fact.